Skip to main content

Advertisement

Log in

Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The purpose of this study is to describe the etiology, characteristics and outcomes of central nervous system (CNS) infections in patients with systemic lupus erythematosus (SLE), while also identifying prognostic and risk factors. Thirty-eight SLE patients with CNS infections were identified from review of all charts of patients with SLE hospitalized from January 1995 to June 2005. These patients were divided into 3 groups, i.e., Mycobacterium tuberculosis (TB), non-TB bacterial and fungal infection groups. Of the 38 SLE cases with CNS infections, TB was identified in 19 patients, Listeria monocytogenes in 3 patients, Klebsiella pneumoniae in 1 patient, Staphylococcus aureus in 1 patient, Gram’s stain positive bacteria in 1 patient, Cryptococcus neoformans in 12 patients, and Aspergillus fumigatus in 1 patient. The rate of unfavorable outcome in patients with fungal infection was lower than in patients with TB (P=0.028) and non-TB bacterial CNS infections (P=0.046). SLE patients with TB or fungal CNS infections had a more insidious or atypical clinical presentation. Compared to SLE patients without CNS infections, those with CNS infections were more likely to have low serum albumin levels (P=0.048) and have been receiving higher doses of prednisolone at the onset of CNS infection (P=0.015) or higher mean doses of prednisolone within the previous year (P=0.039). In conclusion, low levels of serum albumin and higher doses of received prednisolone are important risk factors for the development of CNS infections in SLE patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CNS:

Central nervous system

TB:

Mycobacterium tuberculosis

SLE:

Systemic Lupus Erythematosus

References

  1. Iliopoulos AG, Tsokos GC (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Seminars Arthritis Rheum 25:318–336

    Article  CAS  Google Scholar 

  2. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheim 17:1–10

    Article  CAS  Google Scholar 

  3. Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE (1991) Gluococorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 9:413–423

    PubMed  CAS  Google Scholar 

  4. Duffy KN, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 18:1180–1184

    PubMed  CAS  Google Scholar 

  5. Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492–1499

    Article  PubMed  CAS  Google Scholar 

  6. Ward MM, Pyun E, Studenski S (1995) Long-term survival in systemic lupus erythematosus: patient characteristics associated with poorer outcomes. Arthritis Rheum 38:274–283

    Article  PubMed  CAS  Google Scholar 

  7. Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 19:1559–1565

    PubMed  CAS  Google Scholar 

  8. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A (2001) Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10:505–510

    Article  PubMed  CAS  Google Scholar 

  9. Kraus A, Cabral AR, Sifuentes-Osornio J, Alarcon-Segovia D (1994) Listeriosis in patients with connective tissue disease. J Rheumatol 21:635–638

    PubMed  CAS  Google Scholar 

  10. Liou J, Chiu C, Tseng C, Chi C, Fu L (2003) Cryptococcal meningitis in pediatric systemic lupus erythematosus. Mycoses 46:153–156

    Article  PubMed  CAS  Google Scholar 

  11. Mok CC, Lau CS, Yuen KY (1998) Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 16:169–171

    PubMed  CAS  Google Scholar 

  12. Hung JJ, Ou LS, Lee W, Huang JL (2005) Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 32:40–43

    PubMed  Google Scholar 

  13. Tam LS, Li EK, Wong SM, Szeto CC (2002) Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol 31:296–300

    Article  PubMed  Google Scholar 

  14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  16. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484

    Article  PubMed  CAS  Google Scholar 

  17. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL et al (1997) Bacterial meningitis in the United States in 1995. Active surveillance team. N Engl J Med 337:970–976

    Article  PubMed  CAS  Google Scholar 

  18. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S (1997) Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med 24:425–430

    Article  Google Scholar 

  19. Beek DVD, Gans JD, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849–1859

    Article  PubMed  Google Scholar 

  20. Young LS (1993) Mycobacterial diseases and the compromised host. Clin Infect Dis 17(suppl 2):436–441

    Google Scholar 

  21. Feng PH, Tan TH (1982) Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 41:11–14

    Article  PubMed  CAS  Google Scholar 

  22. Hui ACF, Ngb KC, Tonga PY, Moka V, Chowa KM, Wua A, Wonga LKS (2005) Bacterial meningitis in Hong Kong: 10-years’ experience. Clin Neurol Neuro 107:366-370

    CAS  Google Scholar 

  23. Skogberg K, Ruutu P, Tukiainen P, Valtonen V (1993) Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 17:1012–1017

    PubMed  CAS  Google Scholar 

  24. Stecher DR, Gusis S, Maldonado Cocco JA (1992) Tuberculous arthritis in the course of connective tissue disease: Report of 4 cases. J Rheumatol 19:1418–1420

    PubMed  CAS  Google Scholar 

  25. Gladman DD, Hussain F, Ibanez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234–239

    Article  PubMed  CAS  Google Scholar 

  26. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A (2001) Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10:505–510

    Article  PubMed  CAS  Google Scholar 

  27. Yuhara T, Takemura H, Akama T, Suzuki H, Yamane K, Kashiwagi H (1996) Predicting infection in hospitalized patients with systemic lupus erythematosus. Intern Med 35:629–636

    PubMed  CAS  Google Scholar 

  28. Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475–1482

    Article  PubMed  CAS  Google Scholar 

  29. Cohen J, Pinching AJ, Rees AJ, Peters DK (1982) Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med 201:1–15

    Google Scholar 

  30. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M (1978) Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 21:37–44

    Article  PubMed  CAS  Google Scholar 

  31. ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 17:1642–1648

    PubMed  Google Scholar 

  32. Caldwell JR, Furst DE (1991) The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 21:1–11

    Article  PubMed  CAS  Google Scholar 

  33. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766–1772

    Article  PubMed  CAS  Google Scholar 

  34. Bresnihan B, Cunnane G (2003) Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 29:185–202

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Drs. Michael A. Maldonado and Jingsong Wang for their critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheng-De Yang.

Additional information

This work was supported by a research grant from Shanghai Leading Academic Discipline Project, Project number: T0203 and a research grant 30371332 from National Natural Science Foundation of China (NSFC).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, CD., Wang, XD., Ye, S. et al. Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus. Clin Rheumatol 26, 895–901 (2007). https://doi.org/10.1007/s10067-006-0424-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0424-x

Keywords

Navigation